OPEN END TURBO OPTIONSSCHEIN SHORT - AMGEN | Market Closed - BOERSE MUENCHEN 02:25:52 2024-06-28 pm EDT | ||
| 19.19 EUR | -0.42% |
|
| Current month | -2.59% | ||
| 1 month | -4.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 19.19 | -0.42% |
| 24-06-27 | 19.27 | +0.57% |
| 24-06-26 | 19.16 | +3.79% |
| 24-06-25 | 18.46 | -1.91% |
| 24-06-24 | 18.82 | -3.34% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ4D7K |
| ISIN | DE000GZ4D7K5 |
| Date issued | 2022-11-28 |
| Strike | 518.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 22.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 28.68 € |
|---|---|
| Lowest since issue | 18.11 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
